# Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rituximab-as-maintenance-therapy-for-anti-neutrophil-cytoplasmic-antibody/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Eugene P. Rhee,Karen Laliberte,John L. Niles |
| Citations | 120 |
| DOI | 10.2215/cjn.08821209 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/2924418 |
| OpenAlex ID | https://openalex.org/W2161437160 |
| PMID | 20498238 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Karen Laliberte](https://scholariq.org/researchers/karen-laliberte/)

## Paper journal

- [Clinical Journal of the American Society of Nephrology](https://scholariq.org/journals/clinical-journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

## Paper topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.